NACL Industries Limited has informed the Exchange regarding allotment of 32501851 securities pursuant to Rights Issue at its meeting held on December 31, 2025
NACLIND · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
NACL Industries has completed its rights issue by allotting 3.25 crore equity shares (face value ₹1 each) at ₹76.70 per share on December 31, 2025, raising approximately ₹249.3 crore. The paid-up equity share capital has risen from ₹20.15 crore to ₹23.40 crore, a dilution of about 16% in the share base. The Letter of Offer was issued on December 8, 2025 at a premium of ₹75.70 per share. Additionally, the company is investing ₹83 crore in its wholly owned subsidiary NACL Spec-Chem Limited through 8,300 Compulsorily Convertible Debentures of ₹1 lakh each, to be used by the subsidiary for repaying its existing loans.
Existing shareholders face meaningful share dilution (~16%) while the company strengthens its balance sheet with ~₹249 crore in fresh equity. The ₹83 crore deployment into the subsidiary is for debt repayment rather than growth, which may be neutral to mildly positive if it lowers consolidated interest costs.